Study reveals fast action, right resources are key to treating fulminant myocarditis

New Delhi, Jan 07 (ANI): The resources needed to treat fulminant myocarditis -- severe, inflammation of the heart that develops rapidly -- are outlined in a new Scientific Statement from the American Heart Association on how best to reduce fatalities from this rare condition. The study is published in cardiovascular journal -- Circulation. Fulminant myocarditis, often caused by a viral infection, comes on suddenly and often with significant severity, resulting in an exceptionally high risk of death caused by cardiogenic shock -- the heart's inability to pump enough blood, fatal arrhythmias, and multiorgan failure. With many of today's technology advances, numerous devices can fully support a patient's circulation and oxygenation and ventilation when necessary. The early recognition of fulminant myocarditis, the institution of circulatory support and maintenance of end-organ function, especially avoiding prolonged neurologic hypoxemia, can result in favourable outcomes for this previous